SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-002418
Filing Date
2014-05-12
Accepted
2014-05-12 10:11:39
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctix_10q.htm 10-Q 2069010
2 CERTIFICATION ctix_ex311.htm EX-31.1 16938
3 CERTIFICATION ctix_ex312.htm EX-31.2 16258
4 CERTIFICATION ctix_ex321.htm EX-32.1 7274
5 CERTIFICATION ctix_ex322.htm EX-32.2 8400
6 INTELLECTUAL PROPERTY ACQUIRED FROM POLYMEDIX ctix_ex1037.htm EX-10.37 79364
7 MATERIAL TRANSFER AGREEMENT WITH BETH ISRAEL DEACONESS ctix_ex1038.htm EX-10.38 29645
8 LEASE BETWEEN CELLCEUTIX CORPORATION AND CUMMINGS PROPERTIES LLC ctix_ex1039.htm EX-10.39 1780
9 img001.jpg GRAPHIC 525124
10 img003.jpg GRAPHIC 304222
  Complete submission text file 0001477932-14-002418.txt   3372664
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 14831683
SIC: 2834 Pharmaceutical Preparations